Health research aims to find better ways to treat, prevent and cure disease.
This vital component of healthcare can take multiple forms and present a variety of risks and opportunities. Whether it is a clinical trial, secondary data research, research ethics board protocol review, or a material transfer agreement, we keep the aims of the study top of mind while advising researchers, funders, and health care organizations. We also advise on deidentification of data for research purposes, and questions of research versus quality.
Our services include:
Agreements - Material transfer, clinical trial, data sharing, basic science
Research ethics board advice
Research misconduct
Protocol reviews
Informed consents
Deidentified data
Connect with our team
Mary Jane Dykeman
Samara Starkman
Updated: Feb 4, 2021
The COVID-19 pandemic has prompted a rush of new technology as businesses and governments contend with a stay-at-home economy. In that digital push—and with the private and public sectors increasingly valuing both data and privacy—Toronto-based boutique law firm INQ sees opportunity.
